News
Zacks Investment Research on MSN3h
EXEL Stock Rises on Positive Data From Colorectal Cancer StudyShares of Exelixis, Inc. EXEL gained 7.4% on June 23, after the company announced positive top-line results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback